Physicians Preferred Laboratory LTD
Physicians Preferred Laboratory LTD was paid $351K by Medicaid between Jan 2018 and Dec 2024, across 59 billing codes. Its largest line is U0004, 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r — 28% of everything it billed.
AMARILLO, TX 79119
Next to other Clinical Medical Laboratory providers in Texas
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 9,719 | $2K | |
| 2019 | 7,273 | $1K | |
| 2020 | 7,845 | $57K | |
| 2021 | 12,046 | $121K | |
| 2022 | 9,401 | $94K | |
| 2023 | 8,129 | $51K | |
| 2024incomplete | 4,176 | $25K |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 28% | 1,583 | 1,483 | $99K |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 11% | 1,576 | 1,438 | $39K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 10% | 1,386 | 1,282 | $36K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 10% | 1,384 | 1,280 | $36K |
| 80050 | General health panel | 4.9% | 603 | 578 | $17K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 3.8% | 650 | 614 | $13K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 3.6% | 10,990 | 9,002 | $13K |
| 87088 | 3.5% | 2,891 | 2,704 | $12K | |
| 80053 | Comprehensive metabolic panel | 3.4% | 9,290 | 7,767 | $12K |
| 86703 | 2.4% | 764 | 742 | $8K | |
| 80061 | Lipid panel | 2.2% | 4,448 | 4,286 | $8K |
| 84443 | Thyroid stimulating hormone (TSH) | 2.2% | 3,270 | 3,134 | $8K |
47 more codes
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 1.9% | 582 | $7K |
| 83036 | Hemoglobin; glycosylated (A1C) | 1.4% | 2,753 | $5K |
| 87186 | 1.3% | 1,395 | $5K | |
| 87070 | 1.3% | 771 | $5K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 1.1% | 115 | $4K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 3,946 | $3K |
| 80055 | <1% | 93 | $3K | |
| 83880 | <1% | 716 | $3K | |
| 82607 | <1% | 312 | $2K | |
| 86592 | <1% | 573 | $2K | |
| 86780 | <1% | 158 | $2K | |
| 84439 | <1% | 392 | $1K | |
| 82947 | <1% | 346 | $1K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 59 | $971.04 |
| 81001 | <1% | 528 | $914.28 | |
| 85004 | <1% | 228 | $832.13 | |
| 83735 | <1% | 326 | $797.70 | |
| 85049 | <1% | 236 | $591.52 | |
| 85041 | <1% | 236 | $398.92 | |
| 85048 | <1% | 236 | $336.06 | |
| 86850 | <1% | 42 | $318.07 | |
| 86762 | <1% | 28 | $314.58 | |
| 85014 | <1% | 236 | $314.11 | |
| 85018 | <1% | 236 | $314.04 | |
| 86140 | <1% | 190 | $313.67 | |
| 87340 | <1% | 42 | $311.59 | |
| 80164 | <1% | 159 | $266.78 | |
| 84702 | <1% | 14 | $176.96 | |
| 85651 | <1% | 107 | $168.13 | |
| 86900 | <1% | 43 | $106.90 | |
| 86901 | <1% | 43 | $106.90 | |
| 81003 | <1% | 165 | $94.28 | |
| 82550 | <1% | 95 | $78.59 | |
| 85610 | <1% | 924 | $67.96 | |
| 82746 | <1% | 13 | $60.86 | |
| 82140 | <1% | 18 | $48.96 | |
| 84100 | <1% | 108 | $37.83 | |
| 81000 | <1% | 411 | $31.77 | |
| 82977 | <1% | 212 | $16.32 | |
| 82248 | <1% | 801 | $12.79 | |
| 84460 | <1% | 355 | $2.31 | |
| 84075 | <1% | 355 | $2.28 | |
| 84450 | <1% | 355 | $2.27 | |
| 82247 | <1% | 356 | $2.22 | |
| 82040 | <1% | 355 | $2.20 | |
| 80076 | 0% | 25 | $0.00 | |
| 84436 | 0% | 65 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
| Provider | Location | Paid |
|---|---|---|
| Amarillo Pathology Associates LTD | Amarillo, TX | $113K |
| Amarillo Pathology Group LLP | Amarillo, TX | $96K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.